Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma is a research paper published in Journal of Immunotherapy and Precision Oncology (2024). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P50 CA217674
NCI NIH HHS
Grant: R01 CA244845
National Institutes of Health
Grant: 5R01CA260872-03
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
National Institutes of Health
Grant: 5R01CA260857-03
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
National Institutes of Health
Grant: 5P50CA217674-04
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
National Institutes of Health
Grant: 1R01CA247441-01A1
Vascularized tumor explants for drug testing
FWCI
1.20
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals